Your browser doesn't support javascript.
loading
Differential development of large-cell neuroendocrine or small-cell lung carcinoma upon inactivation of 4 tumor suppressor genes.
Lázaro, Sara; Pérez-Crespo, Miriam; Lorz, Corina; Bernardini, Alejandra; Oteo, Marta; Enguita, Ana Belén; Romero, Eduardo; Hernández, Pilar; Tomás, Laura; Morcillo, Miguel Ángel; Paramio, Jesús M; Santos, Mirentxu.
Affiliation
  • Lázaro S; Molecular Oncology Unit, Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain.
  • Pérez-Crespo M; Institute of Biomedical Research, University Hospital "12 de Octubre," 28041 Madrid, Spain.
  • Lorz C; Molecular Oncology Unit, Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain.
  • Bernardini A; Institute of Biomedical Research, University Hospital "12 de Octubre," 28041 Madrid, Spain.
  • Oteo M; Molecular Oncology Unit, Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain.
  • Enguita AB; Institute of Biomedical Research, University Hospital "12 de Octubre," 28041 Madrid, Spain.
  • Romero E; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
  • Hernández P; Molecular Oncology Unit, Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), 28040 Madrid, Spain.
  • Tomás L; Institute of Biomedical Research, University Hospital "12 de Octubre," 28041 Madrid, Spain.
  • Morcillo MÁ; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain.
  • Paramio JM; Biomedical Applications and Pharmacokinetics Unit, CIEMAT, 28040 Madrid, Spain.
  • Santos M; Pathology Department, University Hospital "12 de Octubre," 28041 Madrid, Spain.
Proc Natl Acad Sci U S A ; 116(44): 22300-22306, 2019 10 29.
Article in En | MEDLINE | ID: mdl-31611390
ABSTRACT
High-grade neuroendocrine lung malignancies (large-cell neuroendocrine cell carcinoma, LCNEC, and small-cell lung carcinoma, SCLC) are among the most deadly lung cancer conditions with no optimal clinical management. The biological relationships between SCLC and LCNEC are still largely unknown and a current matter of debate as growing molecular data reveal high heterogeneity with potential therapeutic consequences. Here we describe murine models of high-grade neuroendocrine lung carcinomas generated by the loss of 4 tumor suppressors. In an Rbl1-null background, deletion of Rb1, Pten, and Trp53 floxed alleles after Ad-CMVcre infection in a wide variety of lung epithelial cells produces LCNEC. Meanwhile, inactivation of these genes using Ad-K5cre in basal cells leads to the development of SCLC, thus differentially influencing the lung cancer type developed. So far, a defined model of LCNEC has not been reported. Molecular and transcriptomic analyses of both models revealed strong similarities to their human counterparts. In addition, a 68Ga-DOTATOC-based molecular-imaging method provides a tool for detection and monitoring the progression of the cancer. These data offer insight into the biology of SCLC and LCNEC, providing a useful framework for development of compounds and preclinical investigations in accurate immunocompetent models.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genes, Tumor Suppressor / Neuroendocrine Tumors / Carcinoma, Small Cell / Lung Neoplasms Limits: Animals / Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2019 Type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Genes, Tumor Suppressor / Neuroendocrine Tumors / Carcinoma, Small Cell / Lung Neoplasms Limits: Animals / Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2019 Type: Article Affiliation country: Spain